Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
53 hedge funds and large institutions have $174M invested in Apollo Endosurgery, Inc. in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 17 closing their positions.
8,354% more call options, than puts
Call options by funds: $11.5M | Put options by funds: $136K
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
58% more capital invested
Capital invested by funds: $110M → $174M (+$64M)
50% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 14
16% less funds holding
Funds holding: 63 → 53 (-10)
59% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$5.28M |
| 2 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$4.92M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.72M |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$2.82M |
| 5 |
AIC
AWM Investment Company
New York
|
+$2.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$11.8M |
| 2 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$1.14M |
| 3 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
-$995K |
| 4 |
RI
RTW Investments
New York
|
-$942K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$716K |
APEN Hedge Fund Activity: Q3 2022 in Review
53 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q3 2022, worth a combined $174M — up 58% from $110M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of APEN and 7 opened new positions — a net loss of 10 holders — while 14 trimmed existing stakes and 21 added.
The largest buyer was Russell Investments Group, opening a new position worth an estimated $5.28M. The largest seller was Soleus Capital Management, cutting an estimated $11.8M.
- 53 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q3 2022, down from 63 in Q2 2022.
- Funds reported $174M of Apollo Endosurgery, Inc. stock for Q3 2022, up 58% quarter-over-quarter.
- 7 funds opened new Apollo Endosurgery, Inc. positions in Q3 2022 and 17 closed out, a net change of -10 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q3 2022 was Russell Investments Group, an estimated $5.28M added.
- The largest Apollo Endosurgery, Inc. seller in Q3 2022 was Soleus Capital Management, an estimated $11.8M sold.
Based on aggregated 13F filings for Q3 2022.